Evaluation of the topical antimycotic treatment in psoriatic onychopathy with severe perionychia
Santagostino, L.; Giorgetti, P.; Di Cintio, R.; Albanese, G.
Giornale Italiano di Dermatologia e Venereologia Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 123(5): 253-259
1988
ISSN/ISBN: 0392-0488 PMID: 3209245 Document Number: 310293
Document emailed within 1 workday
Related Documents
Albanese, G.; Giorgetti, P.; Santagostino, L.; Di Cintio, R.; Colombo, M.D. 1989: Evaluation of the efficacy of a new antimycotic molecule for topical use: naftifine Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 124(5): Xxxiii-XxxviiKrakówka, P.; Walczak, J.; Halweg, H.; Pawlicka, L.; Traczyk, K.; Podsiadlo, B.; Lesiak, B. 1976: Topical treatment of patients with pulmonar aspergillosis with a paste containing antimycotic drugs Pneumonologia Polska 44(11-12): 983-993
Kellner, H.M.; Arnold, C.; Christ, O.E.; Eckert, H.G.; Herok, J.; Hornke, I.; Rupp, W. 1981: Pharmacokinetics and biotransformation of the antimycotic drug ciclopiroxolamine in animals and man after topical and systemic administration Arzneimittel-Forschung 31(8a): 1337-1353
Ogunshe, A.A.O.; Omotoso, O.A.; Akindele, T.M. 2011: Soaps and germicides as adjunct topical antimycotic agents on candida species implicated in vulvovaginal candidasis East African Journal of Public Health 8(2): 112-118
Elizalde-Benito, F.-X.; Elizalde-Benito, A.-G.; Urra-Palos, M.; Quintana-Martínez, I.; Elizalde-Amatria, A.-G. 2019: Severe balanoposthitis secondary to treatment with topical imiquimod Archivos Espanoles de Urologia 72(10): 1056-1057
Cheng, M.W.; Kehl, A.; Worswick, S.; Goh, C. 2018: Successful Treatment of Severe Alopecia Areata with Oral or Topical Tofacitinib Journal of Drugs in Dermatology: Jdd 17(7): 800-803
2003: Calcineurin inhibitors in treatment of atopic dermatitis. Topical corticoids now only in severe outbreaks? MMWFortschrittederMedizin 145(29-30): 62
De Prost, Y.; Teillac, D.; Paquez, F.; Carrugi, C.; Bachelez, H.; Touraine, R. 1988: Treatment of severe alopecia areata by topical applications of cyclosporine: comparative trial versus placebo in 43 patients Transplantation Proceedings 20(3 Suppl 4: 112-113
Lindqvist, U.; Wernroth, M.-L.; Husmark, T.; Larsson, P.; Geijer, M.; Teleman, A.; Theander, E.; Alenius, G.-M. 2017: DAPSA, DAS28 and MDA predict long-term treatment regime in psoriatic arthritis. the Swedish Early Psoriatic Arthritis Cohort Clinical and Experimental Rheumatology 35(6): 936-942
Qadripur, S.A. 1983: Antimycotic therapy. 3: Polyene antimycotic antibiotics, antimycotic antibiotics without polyene structure Fortschritte der Medizin 101(11): 465-469
Flanagan, K.H.; King, R.; Glaser, D.A. 2008: Botulinum toxin type a versus topical 20% aluminum chloride for the treatment of moderate to severe primary focal axillary hyperhidrosis Journal of Drugs in Dermatology: Jdd 7(3): 221-227
Nasir, A.; Goldstein, B.; van Cleeff, M.; Swick, L. 2011: Clinical evaluation of safety and efficacy of a new topical treatment for onychomycosis Journal of Drugs in Dermatology: Jdd 10(10): 1186-1191
Reichrath, J.; Perez, A.; Müller, S.M.; Chen, T.C.; Kerber, A.; Bahmer, F.A.; Holick, M.F. 1997: Topical calcitriol (1,25-dihydroxyvitamin D3) treatment of psoriasis: an immunohistological evaluation Acta Dermato-Venereologica 77(4): 268-272
Berardesca, E.; Vignoli, G.P.; Farinelli, N.; Vignini, M.; Distante, F.; Rabbiosi, G. 1994: Non-invasive evaluation of topical calcipotriol versus clobetasol in the treatment of psoriasis Acta Dermato-Venereologica 74(4): 302-304
León, G.; Mosca, W.; Arguello, A. 1988: In vitro evaluation of the trypanocidal activity of 3 antimycotic agents on fresh plasma infected with T. cruzi Acta Cientifica Venezolana 39(4): 344-348
Moore, A.; Kempers, S.; Murakawa, G.; Weiss, J.; Tauscher, A.; Swinyer, L.; Liu, H.; Leoni, M. 2014: Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study Journal of Drugs in Dermatology: Jdd 13(1): 56-61
Glogau, R.; Blitzer, A.; Brandt, F.; Kane, M.; Monheit, G.D.; Waugh, J.M. 2012: Results of a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a botulinum toxin type a topical gel for the treatment of moderate-to-severe lateral canthal lines Journal of Drugs in Dermatology: Jdd 11(1): 38-45
Fowler, J.; Jackson, M.; Moore, A.; Jarratt, M.; Jones, T.; Meadows, K.; Steinhoff, M.; Rudisill, D.; Leoni, M. 2013: Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies Journal of Drugs in Dermatology: Jdd 12(6): 650-656
Gold, M.H.; Gallagher, C. 2013: An evaluation of the benefits of a topical treatment in the improvement of photodamaged hands with age spots, freckles, and/or discolorations Journal of Drugs in Dermatology: Jdd 12(12): 1468-1472
Schubert, B.; Minard, J.J.; Baran, R.; Verret, J.L.; Schnitzler, L. 1977: Onychopathy of mushroom-growers Annales de Dermatologie et de Venereologie 104(10): 627-630